世界の小児臨床試験市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pediatric Clinical Trials Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4672 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、小児臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（前臨床フェーズ、フェーズI、フェーズII、フェーズIII）、用途別市場規模（精神神経疾患、感染症、呼吸器疾患、心血管疾患、がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・小児臨床試験の市場動向 ・企業の競争状況、市場シェア ・小児臨床試験の種類別市場規模と予測2016-2027（前臨床フェーズ、フェーズI、フェーズII、フェーズIII） ・小児臨床試験の用途別市場規模と予測2016-2027（精神神経疾患、感染症、呼吸器疾患、心血管疾患、がん、その他） ・小児臨床試験の北米市場規模2016-2027（アメリカ、カナダ） ・小児臨床試験の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・小児臨床試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・小児臨床試験の中南米市場規模2016-2027（メキシコ、ブラジル） ・小児臨床試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（IQVIA Holdings, Inc.、Parexel International、CenterWatch、Syneos Health、Charles River Laboratories、Covance Inc.、ICON Plc.、Pharmaceutical Product Development, LLC.、Genentech (Roche)、Pfizer、Bristol-Myers Squibb、GlaxoSmithKline、Sanofi S.A.、Novartis AG、Johnson & Johnson、Shire (Takeda)） ・結論

Market Analysis and Insights: Global Pediatric Clinical Trials Market
The global Pediatric Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Clinical Trials market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Clinical Trials market.

Global Pediatric Clinical Trials Scope and Market Size
Pediatric Clinical Trials market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pre-Clinical Phase
Phase I
Phase II
Phase III

Segment by Application
Neuropsychiatric Conditions
Infectious Diseases
Respiratory Diseases
Cardiovascular Diseases
Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
IQVIA Holdings, Inc.
Parexel International
CenterWatch
Syneos Health
Charles River Laboratories
Covance Inc.
ICON Plc.
Pharmaceutical Product Development, LLC.
Genentech (Roche)
Pfizer
Bristol-Myers Squibb
GlaxoSmithKline
Sanofi S.A.
Novartis AG
Johnson & Johnson
Shire (Takeda)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Clinical Trials Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pre-Clinical Phase
1.2.3 Phase I
1.2.4 Phase II
1.2.5 Phase III
1.3 Market by Application
1.3.1 Global Pediatric Clinical Trials Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Neuropsychiatric Conditions
1.3.3 Infectious Diseases
1.3.4 Respiratory Diseases
1.3.5 Cardiovascular Diseases
1.3.6 Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pediatric Clinical Trials Market Perspective (2016-2027)
2.2 Pediatric Clinical Trials Growth Trends by Regions
2.2.1 Pediatric Clinical Trials Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pediatric Clinical Trials Historic Market Share by Regions (2016-2021)
2.2.3 Pediatric Clinical Trials Forecasted Market Size by Regions (2022-2027)
2.3 Pediatric Clinical Trials Industry Dynamic
2.3.1 Pediatric Clinical Trials Market Trends
2.3.2 Pediatric Clinical Trials Market Drivers
2.3.3 Pediatric Clinical Trials Market Challenges
2.3.4 Pediatric Clinical Trials Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pediatric Clinical Trials Players by Revenue
3.1.1 Global Top Pediatric Clinical Trials Players by Revenue (2016-2021)
3.1.2 Global Pediatric Clinical Trials Revenue Market Share by Players (2016-2021)
3.2 Global Pediatric Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediatric Clinical Trials Revenue
3.4 Global Pediatric Clinical Trials Market Concentration Ratio
3.4.1 Global Pediatric Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Clinical Trials Revenue in 2020
3.5 Pediatric Clinical Trials Key Players Head office and Area Served
3.6 Key Players Pediatric Clinical Trials Product Solution and Service
3.7 Date of Enter into Pediatric Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Clinical Trials Breakdown Data by Type
4.1 Global Pediatric Clinical Trials Historic Market Size by Type (2016-2021)
4.2 Global Pediatric Clinical Trials Forecasted Market Size by Type (2022-2027)

5 Pediatric Clinical Trials Breakdown Data by Application
5.1 Global Pediatric Clinical Trials Historic Market Size by Application (2016-2021)
5.2 Global Pediatric Clinical Trials Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pediatric Clinical Trials Market Size (2016-2027)
6.2 North America Pediatric Clinical Trials Market Size by Type
6.2.1 North America Pediatric Clinical Trials Market Size by Type (2016-2021)
6.2.2 North America Pediatric Clinical Trials Market Size by Type (2022-2027)
6.2.3 North America Pediatric Clinical Trials Market Size by Type (2016-2027)
6.3 North America Pediatric Clinical Trials Market Size by Application
6.3.1 North America Pediatric Clinical Trials Market Size by Application (2016-2021)
6.3.2 North America Pediatric Clinical Trials Market Size by Application (2022-2027)
6.3.3 North America Pediatric Clinical Trials Market Size by Application (2016-2027)
6.4 North America Pediatric Clinical Trials Market Size by Country
6.4.1 North America Pediatric Clinical Trials Market Size by Country (2016-2021)
6.4.2 North America Pediatric Clinical Trials Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pediatric Clinical Trials Market Size (2016-2027)
7.2 Europe Pediatric Clinical Trials Market Size by Type
7.2.1 Europe Pediatric Clinical Trials Market Size by Type (2016-2021)
7.2.2 Europe Pediatric Clinical Trials Market Size by Type (2022-2027)
7.2.3 Europe Pediatric Clinical Trials Market Size by Type (2016-2027)
7.3 Europe Pediatric Clinical Trials Market Size by Application
7.3.1 Europe Pediatric Clinical Trials Market Size by Application (2016-2021)
7.3.2 Europe Pediatric Clinical Trials Market Size by Application (2022-2027)
7.3.3 Europe Pediatric Clinical Trials Market Size by Application (2016-2027)
7.4 Europe Pediatric Clinical Trials Market Size by Country
7.4.1 Europe Pediatric Clinical Trials Market Size by Country (2016-2021)
7.4.2 Europe Pediatric Clinical Trials Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pediatric Clinical Trials Market Size (2016-2027)
8.2 Asia-Pacific Pediatric Clinical Trials Market Size by Type
8.2.1 Asia-Pacific Pediatric Clinical Trials Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pediatric Clinical Trials Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pediatric Clinical Trials Market Size by Type (2016-2027)
8.3 Asia-Pacific Pediatric Clinical Trials Market Size by Application
8.3.1 Asia-Pacific Pediatric Clinical Trials Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pediatric Clinical Trials Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pediatric Clinical Trials Market Size by Application (2016-2027)
8.4 Asia-Pacific Pediatric Clinical Trials Market Size by Region
8.4.1 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pediatric Clinical Trials Market Size (2016-2027)
9.2 Latin America Pediatric Clinical Trials Market Size by Type
9.2.1 Latin America Pediatric Clinical Trials Market Size by Type (2016-2021)
9.2.2 Latin America Pediatric Clinical Trials Market Size by Type (2022-2027)
9.2.3 Latin America Pediatric Clinical Trials Market Size by Type (2016-2027)
9.3 Latin America Pediatric Clinical Trials Market Size by Application
9.3.1 Latin America Pediatric Clinical Trials Market Size by Application (2016-2021)
9.3.2 Latin America Pediatric Clinical Trials Market Size by Application (2022-2027)
9.3.3 Latin America Pediatric Clinical Trials Market Size by Application (2016-2027)
9.4 Latin America Pediatric Clinical Trials Market Size by Country
9.4.1 Latin America Pediatric Clinical Trials Market Size by Country (2016-2021)
9.4.2 Latin America Pediatric Clinical Trials Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pediatric Clinical Trials Market Size (2016-2027)
10.2 Middle East & Africa Pediatric Clinical Trials Market Size by Type
10.2.1 Middle East & Africa Pediatric Clinical Trials Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pediatric Clinical Trials Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pediatric Clinical Trials Market Size by Type (2016-2027)
10.3 Middle East & Africa Pediatric Clinical Trials Market Size by Application
10.3.1 Middle East & Africa Pediatric Clinical Trials Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pediatric Clinical Trials Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pediatric Clinical Trials Market Size by Application (2016-2027)
10.4 Middle East & Africa Pediatric Clinical Trials Market Size by Country
10.4.1 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 IQVIA Holdings, Inc.
11.1.1 IQVIA Holdings, Inc. Company Details
11.1.2 IQVIA Holdings, Inc. Business Overview
11.1.3 IQVIA Holdings, Inc. Pediatric Clinical Trials Introduction
11.1.4 IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2016-2021)
11.1.5 IQVIA Holdings, Inc. Recent Development
11.2 Parexel International
11.2.1 Parexel International Company Details
11.2.2 Parexel International Business Overview
11.2.3 Parexel International Pediatric Clinical Trials Introduction
11.2.4 Parexel International Revenue in Pediatric Clinical Trials Business (2016-2021)
11.2.5 Parexel International Recent Development
11.3 CenterWatch
11.3.1 CenterWatch Company Details
11.3.2 CenterWatch Business Overview
11.3.3 CenterWatch Pediatric Clinical Trials Introduction
11.3.4 CenterWatch Revenue in Pediatric Clinical Trials Business (2016-2021)
11.3.5 CenterWatch Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health Pediatric Clinical Trials Introduction
11.4.4 Syneos Health Revenue in Pediatric Clinical Trials Business (2016-2021)
11.4.5 Syneos Health Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Pediatric Clinical Trials Introduction
11.5.4 Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2016-2021)
11.5.5 Charles River Laboratories Recent Development
11.6 Covance Inc.
11.6.1 Covance Inc. Company Details
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Pediatric Clinical Trials Introduction
11.6.4 Covance Inc. Revenue in Pediatric Clinical Trials Business (2016-2021)
11.6.5 Covance Inc. Recent Development
11.7 ICON Plc.
11.7.1 ICON Plc. Company Details
11.7.2 ICON Plc. Business Overview
11.7.3 ICON Plc. Pediatric Clinical Trials Introduction
11.7.4 ICON Plc. Revenue in Pediatric Clinical Trials Business (2016-2021)
11.7.5 ICON Plc. Recent Development
11.8 Pharmaceutical Product Development, LLC.
11.8.1 Pharmaceutical Product Development, LLC. Company Details
11.8.2 Pharmaceutical Product Development, LLC. Business Overview
11.8.3 Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Introduction
11.8.4 Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2016-2021)
11.8.5 Pharmaceutical Product Development, LLC. Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Pediatric Clinical Trials Introduction
11.9.4 Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2016-2021)
11.9.5 Genentech (Roche) Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Pediatric Clinical Trials Introduction
11.10.4 Pfizer Revenue in Pediatric Clinical Trials Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Pediatric Clinical Trials Introduction
11.11.4 Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Pediatric Clinical Trials Introduction
11.12.4 GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2016-2021)
11.12.5 GlaxoSmithKline Recent Development
11.13 Sanofi S.A.
11.13.1 Sanofi S.A. Company Details
11.13.2 Sanofi S.A. Business Overview
11.13.3 Sanofi S.A. Pediatric Clinical Trials Introduction
11.13.4 Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2016-2021)
11.13.5 Sanofi S.A. Recent Development
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Pediatric Clinical Trials Introduction
11.14.4 Novartis AG Revenue in Pediatric Clinical Trials Business (2016-2021)
11.14.5 Novartis AG Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Pediatric Clinical Trials Introduction
11.15.4 Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2016-2021)
11.15.5 Johnson & Johnson Recent Development
11.16 Shire (Takeda)
11.16.1 Shire (Takeda) Company Details
11.16.2 Shire (Takeda) Business Overview
11.16.3 Shire (Takeda) Pediatric Clinical Trials Introduction
11.16.4 Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2016-2021)
11.16.5 Shire (Takeda) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pediatric Clinical Trials Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pre-Clinical Phase
Table 3. Key Players of Phase I
Table 4. Key Players of Phase II
Table 5. Key Players of Phase III
Table 6. Global Pediatric Clinical Trials Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pediatric Clinical Trials Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pediatric Clinical Trials Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Pediatric Clinical Trials Market Share by Regions (2016-2021)
Table 10. Global Pediatric Clinical Trials Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Pediatric Clinical Trials Market Share by Regions (2022-2027)
Table 12. Pediatric Clinical Trials Market Trends
Table 13. Pediatric Clinical Trials Market Drivers
Table 14. Pediatric Clinical Trials Market Challenges
Table 15. Pediatric Clinical Trials Market Restraints
Table 16. Global Pediatric Clinical Trials Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Pediatric Clinical Trials Market Share by Players (2016-2021)
Table 18. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Clinical Trials as of 2020)
Table 19. Ranking of Global Top Pediatric Clinical Trials Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Pediatric Clinical Trials Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pediatric Clinical Trials Product Solution and Service
Table 23. Date of Enter into Pediatric Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pediatric Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Pediatric Clinical Trials Revenue Market Share by Type (2016-2021)
Table 27. Global Pediatric Clinical Trials Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Pediatric Clinical Trials Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Pediatric Clinical Trials Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Pediatric Clinical Trials Revenue Market Share by Application (2016-2021)
Table 31. Global Pediatric Clinical Trials Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Pediatric Clinical Trials Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Pediatric Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Pediatric Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Pediatric Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Pediatric Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Pediatric Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Pediatric Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Pediatric Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Pediatric Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Pediatric Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Pediatric Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Pediatric Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Pediatric Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pediatric Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pediatric Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pediatric Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pediatric Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Pediatric Clinical Trials Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Pediatric Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Pediatric Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Pediatric Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Pediatric Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Pediatric Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Pediatric Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pediatric Clinical Trials Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pediatric Clinical Trials Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pediatric Clinical Trials Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pediatric Clinical Trials Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Pediatric Clinical Trials Market Size by Country (2022-2027) & (US$ Million)
Table 63. IQVIA Holdings, Inc. Company Details
Table 64. IQVIA Holdings, Inc. Business Overview
Table 65. IQVIA Holdings, Inc. Pediatric Clinical Trials Product
Table 66. IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 67. IQVIA Holdings, Inc. Recent Development
Table 68. Parexel International Company Details
Table 69. Parexel International Business Overview
Table 70. Parexel International Pediatric Clinical Trials Product
Table 71. Parexel International Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 72. Parexel International Recent Development
Table 73. CenterWatch Company Details
Table 74. CenterWatch Business Overview
Table 75. CenterWatch Pediatric Clinical Trials Product
Table 76. CenterWatch Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 77. CenterWatch Recent Development
Table 78. Syneos Health Company Details
Table 79. Syneos Health Business Overview
Table 80. Syneos Health Pediatric Clinical Trials Product
Table 81. Syneos Health Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 82. Syneos Health Recent Development
Table 83. Charles River Laboratories Company Details
Table 84. Charles River Laboratories Business Overview
Table 85. Charles River Laboratories Pediatric Clinical Trials Product
Table 86. Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 87. Charles River Laboratories Recent Development
Table 88. Covance Inc. Company Details
Table 89. Covance Inc. Business Overview
Table 90. Covance Inc. Pediatric Clinical Trials Product
Table 91. Covance Inc. Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 92. Covance Inc. Recent Development
Table 93. ICON Plc. Company Details
Table 94. ICON Plc. Business Overview
Table 95. ICON Plc. Pediatric Clinical Trials Product
Table 96. ICON Plc. Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 97. ICON Plc. Recent Development
Table 98. Pharmaceutical Product Development, LLC. Company Details
Table 99. Pharmaceutical Product Development, LLC. Business Overview
Table 100. Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 101. Pharmaceutical Product Development, LLC. Recent Development
Table 102. Genentech (Roche) Company Details
Table 103. Genentech (Roche) Business Overview
Table 104. Genentech (Roche) Pediatric Clinical Trials Product
Table 105. Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 106. Genentech (Roche) Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Pediatric Clinical Trials Product
Table 110. Pfizer Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 111. Pfizer Recent Development
Table 112. Bristol-Myers Squibb Company Details
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Pediatric Clinical Trials Product
Table 115. Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. GlaxoSmithKline Company Details
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Pediatric Clinical Trials Product
Table 120. GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 121. GlaxoSmithKline Recent Development
Table 122. Sanofi S.A. Company Details
Table 123. Sanofi S.A. Business Overview
Table 124. Sanofi S.A. Pediatric Clinical Trials Product
Table 125. Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 126. Sanofi S.A. Recent Development
Table 127. Novartis AG Company Details
Table 128. Novartis AG Business Overview
Table 129. Novartis AG Pediatric Clinical Trials Product
Table 130. Novartis AG Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 131. Novartis AG Recent Development
Table 132. Johnson & Johnson Company Details
Table 133. Johnson & Johnson Business Overview
Table 134. Johnson & Johnson Pediatric Clinical Trials Product
Table 135. Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 136. Johnson & Johnson Recent Development
Table 137. Shire (Takeda) Company Details
Table 138. Shire (Takeda) Business Overview
Table 139. Shire (Takeda) Pediatric Clinical Trials Product
Table 140. Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2016-2021) & (US$ Million)
Table 141. Shire (Takeda) Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Clinical Trials Market Share by Type: 2020 VS 2027
Figure 2. Pre-Clinical Phase Features
Figure 3. Phase I Features
Figure 4. Phase II Features
Figure 5. Phase III Features
Figure 6. Global Pediatric Clinical Trials Market Share by Application: 2020 VS 2027
Figure 7. Neuropsychiatric Conditions Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Respiratory Diseases Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Pediatric Clinical Trials Report Years Considered
Figure 14. Global Pediatric Clinical Trials Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Pediatric Clinical Trials Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Pediatric Clinical Trials Market Share by Regions: 2020 VS 2027
Figure 17. Global Pediatric Clinical Trials Market Share by Regions (2022-2027)
Figure 18. Global Pediatric Clinical Trials Market Share by Players in 2020
Figure 19. Global Top Pediatric Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Clinical Trials as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Pediatric Clinical Trials Revenue in 2020
Figure 21. Global Pediatric Clinical Trials Revenue Market Share by Type (2016-2021)
Figure 22. Global Pediatric Clinical Trials Revenue Market Share by Type (2022-2027)
Figure 23. North America Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Pediatric Clinical Trials Market Share by Type (2016-2027)
Figure 25. North America Pediatric Clinical Trials Market Share by Application (2016-2027)
Figure 26. North America Pediatric Clinical Trials Market Share by Country (2016-2027)
Figure 27. United States Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Pediatric Clinical Trials Market Share by Type (2016-2027)
Figure 31. Europe Pediatric Clinical Trials Market Share by Application (2016-2027)
Figure 32. Europe Pediatric Clinical Trials Market Share by Country (2016-2027)
Figure 33. Germany Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Pediatric Clinical Trials Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Pediatric Clinical Trials Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Pediatric Clinical Trials Market Share by Region (2016-2027)
Figure 43. China Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Pediatric Clinical Trials Market Share by Type (2016-2027)
Figure 51. Latin America Pediatric Clinical Trials Market Share by Application (2016-2027)
Figure 52. Latin America Pediatric Clinical Trials Market Share by Country (2016-2027)
Figure 53. Mexico Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Pediatric Clinical Trials Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Pediatric Clinical Trials Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Pediatric Clinical Trials Market Share by Country (2016-2027)
Figure 59. Turkey Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Pediatric Clinical Trials Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. IQVIA Holdings, Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 63. Parexel International Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 64. CenterWatch Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 65. Syneos Health Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 66. Charles River Laboratories Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 67. Covance Inc. Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 68. ICON Plc. Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 69. Pharmaceutical Product Development, LLC. Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 70. Genentech (Roche) Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 72. Bristol-Myers Squibb Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 73. GlaxoSmithKline Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 74. Sanofi S.A. Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 75. Novartis AG Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 76. Johnson & Johnson Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 77. Shire (Takeda) Revenue Growth Rate in Pediatric Clinical Trials Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

---